Aspiration pneumonitis

Summary

Aspiration pneumonitis (MONDO:0002572) is a disease and 4 clinical trials. A subtype of pneumonitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 4

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	aspiration pneumonitis
Mondo ID	MONDO:0002572
EFO	EFO:1001399
DOID	DOID:3240
NCIT	C34932
SNOMED CT	155597006
UMLS	C1761609
MedGen	740734
Is cancer (heuristic)	no

Also known as: chemical pneumonitis

Disease family

This is a subtype of pneumonitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › lower respiratory tract disorder › lung disorder › pneumonitis › aspiration pneumonitis

Related subtypes (5): toxic pneumonitis, pneumonia, ichthyosis prematurity syndrome, hypersensitivity pneumonitis, radiation pneumonitis

Subtypes (1): lipid pneumonia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated or in trials for this disease

No drug has an approved disease-direct ChEMBL indication for this disease.

1 drug in clinical trials for this disease (phase 2–3, investigational): efficacy not established — a trial record, not an indication.

Drug	Highest phase
Nitric Oxide	Phase 3

Clinical trials & evidence

Clinical trials

Clinical trials: 4.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	4

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07186933	Not specified	RECRUITING	Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications
NCT02419196	Not specified	COMPLETED	Perioperative Change of Regional Ventilation During Spontaneous Breathing
NCT02779595	Not specified	COMPLETED	Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery
NCT03828500	Not specified	UNKNOWN	Preoperative Fasting for Ambulatory Cataract Surgery: The PRACTICE Study